Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

August 2011 Patent Group Lunch


Published on

Topics covered in this month’s presentation included:
• Federal Circuit “computer readable medium” claim eligibility
• Update on patent eligibility of isolated DNA
• USPTO’s Ombudsman Program became permanent
• USPTO just issued Patent No. 8,000,000

  • Be the first to comment

  • Be the first to like this

August 2011 Patent Group Lunch

  1. 1. Prosecution Group Luncheon Patents August, 2011
  2. 2. The Disk is Only As Good As the Software <ul><li>CyberSource Corp. v. Retail Decisions, Inc . (Fed Cir. 2011) </li></ul><ul><li>Method claim: anti-fraud process for online credit card purchases </li></ul><ul><ul><li>Claim 2: a &quot;computer readable medium containing program instructions&quot; for causing a computer to perform that method </li></ul></ul><ul><li>FC: “Computer-readable medium” with ineligible process is not a patent-eligible product </li></ul><ul><ul><li>Method is an unpatentable mental process standing alone </li></ul></ul><ul><ul><li>Claim 2 is &quot;nothing more than a computer readable medium containing program instructions for executing the method&quot; </li></ul></ul><ul><ul><li>Court turned away from literal statutory category </li></ul></ul><ul><ul><li>(article of manufacture), toward &quot;underlying invention&quot; </li></ul></ul><ul><ul><li>Patentee unable to show that “computer readable </li></ul></ul><ul><ul><li>medium” was fundamentally different from method </li></ul></ul>
  3. 3. But Isolated DNA Is Eligible <ul><li>Assn. for Molecular Pathology v. Myriad Genetics (FC 2011) </li></ul><ul><li>District court invalidated claims to isolated naturally-occurring DNA material </li></ul><ul><li>FC: Reversed invalidity of claims to screening cancer treatments via changes in cell growth rates </li></ul><ul><li>Reversed invalidity of claims directed to isolated DNA </li></ul><ul><li>Dissent: process of isolating genetic material does not make that material a patentable invention </li></ul><ul><li>En banc petition or petition for cert. expected </li></ul>
  4. 4. Ombudsman Program Made Permanent <ul><li>To assist applicants with issues that arise during prosecution, especially when there is a breakdown in the normal process </li></ul><ul><ul><li>Status inquiries </li></ul></ul><ul><ul><li>Petitions issues </li></ul></ul><ul><li>To provide a channel for resolving issues that may not fit into existing channels </li></ul><ul><li> </li></ul>
  5. 5. Milestones <ul><li>Patent No. 8,000,000 </li></ul><ul><li>Second Sight Medical Products </li></ul><ul><li>Visual Prosthesis </li></ul><ul><li>5 ½ years since 7,000,000 </li></ul><ul><li>(Feb. 2006) </li></ul><ul><li>6,000,000 in Dec. 1999 </li></ul>